Sanofi gets rated buy today, agreeing with bullish ratings from the Wall Street and SA analysts' consensus. With a diverse ...
Massachusetts-based Ring Therapeutics has partnered with Singapore’s A*STAR and SERI to advance gene therapy using its ...
(RTTNews) - Sanofi announced that Beyfortus (nirsevimab) will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest Territories, and the Yukon this fall. The administration ...
Office workers walk out for a lunch break at Raffles Place central business district in Singapore on Oct 6, 2022. (File photo: AFP/Roslan RAHMAN) New: You can now listen to articles. SINGAPORE ...
Sanofi (Euronext: SAN) reported 15.7% sales growth for the third quarter of 2024 reaching 13.4 billion euros ($14.2 billion), with adjusted earnings per share (EPS) rising by 12.2% to 2.86 euros, ...
Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...
Sanofi expects a low single-digit decline in flu shot sales due to the soft vaccination rate. Sanofi reaffirms that Dupixent will deliver around 13 billion euros in 2024 sales. The company ...
SINGAPORE: During the ongoing trial of Workers’ Party (WP) chief Pritam Singh for allegedly lying before a Committee of Privileges, a former party cadre was called up as a witness. The term will ...
(Reuters) - French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, boosted by an earlier-than-anticipated start of the vaccination season.
Leerink Partners analyst David Risinger in a Friday note to investors said Sanofi expects Q4 Beyfortus sales similar to Q3. Sanofi released its third-quarter earnings report on Friday, beating ...
Sanofi reported a 25% boost in sales for its vaccines division during the third quarter, helped by earlier-than-anticipated orders of its flu shots as well as rising revenue from Beyfortus, its RSV ...
Irish boyband Westlife, wildly popular in Asia, was last in Singapore in February 2023 for a three-night concert. (File photo: Universal Music Singapore) New: You can now listen to articles. Belting ...